HMN 2025: What the Walgreens buyout might imply for the way forward for pharmacy care

Pharmacies are extra than simply shops—they’re important hyperlinks between folks and their well being care.

One of us, Patrick, witnessed this firsthand in 2003 whereas working as a pharmacy technician at Walgreens in a midsize West Texas city. Each day concerned dealing with lots of of prescriptions as they moved via the system—meticulously counting drugs, deciphering docs’ handwriting and finding out complicated insurance coverage points. The {experience} revealed that how pharmacies are owned and managed is as a lot a public well being challenge as it’s a monetary one.

Fast-forward to in the present day, and Walgreens—one of many world’s largest pharmacy chains, which filled nearly 800 million U.S. prescriptions in 2024—is at a turning mark. In March, the corporate announced it would be acquired by personal fairness agency Sycamore Partners for US$10 billion, simply 10% of its peak market worth. That deal takes the storied pharmacy chain off the general public marketplace for the primary time in nearly 100 years.

We’re professors who study the intersection of medicine and business, and we predict this deal affords a window into the way forward for pharmacy care. It issues not simply to pharmacists but additionally to the tens of tens of millions of Americans who depend on shops like Walgreens to satisfy their on a regular basis well being wants.

The rise and struggles of Walgreens

So much has modified within the pharmacy trade since 1901, when Charles R. Walgreen Sr. bought the Chicago drugstore where he served as a pharmacist. The firm went public in 1927, expanded rapidly all through the twentieth century and grew to eight,000 shops by 2013. By 2014, a merger with the European pharmacy chain Alliance Boots made Walgreens one of many largest pharmacy chains on the planet.

More lately, nevertheless, the image for the pharmacy trade hasn’t been so rosy. Labor prices have risen. Front-end retail gross sales—issues like snacks, greeting playing cards and cosmetics—have fallen. And monetary pressures from pharmacy profit managers—these third-party teams that handle the price of prescription drug advantages on the behalf of insurers—have grown.

All of this stuff have considerably constrained revenues throughout the trade, main shops to shutter. Some estimates counsel that as many as one-third of U.S. retail pharmacies have closed since 2010.

Against that backdrop, Sycamore Partners’ March acquisition of Walgreens raises massive questions. What does Sycamore see on this funding, and what would possibly their methods indicate about the way forward for American pharmacy care?

Framing the personal fairness wager

Private fairness companies sometimes purchase corporations, streamline their operations and search to promote them for a revenue inside 5 to seven years of the acquisition.

This rising motion of personal fairness into the worldwide economic system is under no circumstances restricted to well being care. In 2020, personal fairness companies employed 11.7 million U.S. workers, or about 7% of the nation’s complete workforce. The complete property underneath administration by such buyers have grown by over 11% yearly over bygone days twenty years, a pattern that is expected to continue.

In Walgreens, Sycamore, like many of those companies, probably sees a chance to purchase low, reduce prices and enhance profitability. One survey of personal fairness buyers discovered that the most typical self-reported sources of worth creation in these offers for corporations of Sycamore’s measurement have been altering the product and advertising and marketing it extra robustly to drive demand, altering incentives for these throughout the enterprise, and facilitating a high-value exit.

While personal house owners might have extra persistence than public markets, critics argue that personal fairness companies are inclined to have a short-term focus, searching for fast, predictable providers of margin enchancment—like, for instance, chopping jobs.

There’s some proof in favor of that declare. One study discovered that employment often drops within the years following a personal fairness buyout. And if the main target shifts to repaying debt or prepping for resale, long-term tasks, similar to investing in future innovation, can get deprioritized.

The historical past of privatized public corporations affords a mixture of successes and failures. Dell Technologies and lodge chain Hilton are two distinguished examples of corporations that went personal, restructured efficiently and came back stronger. In these circumstances, going personal helped administration focus with out the fixed stress of quarterly earnings stories.

On the opposite hand, corporations similar to Toys R Us, which was taken personal in 2005 and filed for chapter in 2018, present how excessive debt and missed innovation can result in collapse.

What’s subsequent for Walgreens

So, where does this depart Walgreens ? and the buyers concerned within the deal?

If a part of the returns will probably be pushed by “shopping for low”—the simplest indicator of potential future success to measure as of in the present day—Sycamore began properly: Its buy worth represents a mere 8% premium over the market buying and selling worth on the day of the announcement, considerably lower than the 46% seen throughout industries in 2023. That stated, Sycamore financed 83.4% of the acquisition with debt, a quantity on the high end for these kinds of transactions. Health care groups have pointed to this quantity whereas raising concerns that innovation-focused investments might take a back seat to debt obligations.

As the mud settles on the acquisition, Sycamore has indicated an interest in splitting Walgreens into three enterprise models: one targeted on U.S. pharmacies, one on U.Okay. pharmacies and one on U.S. main well being care via its VillageMD subsidiary.

That’s common: Sycamore has used an identical method earlier than with its funding within the office supply retailer Staples, a technique that has garnered sturdy monetary returns however been called into question for its long-term sustainability.

Given the significant financial challenges VillageMD has confronted since its acquisition by Walgreens, this represents a chance to individually consider and optimize its efficiency. Meanwhile, Sycamore’s historic concentrate on retail and customer-focused companies would possibly assist it modernize the in-store {experience} or optimize staffing.

For greater than a century, Walgreens has survived and tailored to sweeping modifications in retail. Now, it is coming into a brand new chapter—one that might reshape not simply its personal future however the position of pharmacies in American life.

Will Sycamore assist Walgreens thrive, utilizing its sources to strengthen providers and ship extra worth to clients? Or will stress to generate fast returns create issues? Either approach, the reply issues—not only for buyers however for anybody who’s ever relied on their neighborhood pharmacy to remain wholesome.

This article is republished from The Conversation underneath a Creative Commons license. Read the unique article.